Delaware
(State or other jurisdiction of
incorporation or organization)
|
001-42303
(Commission File Number)
|
93-4440048
(I.R.S. Employer Identification Number)
|
||||||
6900 Tavistock Lakes Blvd, Suite 400
Orlando, Florida 32827
| ||||||||
(Address of principal executive offices and zip code) | ||||||||
(321) 209-6787 | ||||||||
(Registrant's telephone number, including area code) |
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
||||
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
||||
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
||||
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act: | ||||||||
Title of each class |
Trading Symbol |
Name of each exchange on which registered |
||||||
Common Stock, par value $0.0001 per share | INV | The Nasdaq Stock Market, LLC |
Exhibit Number | Description of Exhibit | ||||
99.1 | |||||
104 | Cover Page Interactive Data File (formatted in Inline XBRL) |
INNVENTURE, INC. | |||||||||||
Date: April 11, 2025 |
By: |
/s/ David Yablunosky | |||||||||
Name: |
David Yablunosky | ||||||||||
Title: |
Chief Financial Officer |
Successor | Predecessor | |||||||||||||
December 31, 2024 | December 31, 2023 | |||||||||||||
Assets | ||||||||||||||
Cash, cash equivalents and restricted cash | $ | 11,119 | $ | 2,575 | ||||||||||
Accounts receivable | 283 | — | ||||||||||||
Due from related parties | 4,536 | 2,602 | ||||||||||||
Inventories | 5,178 | — | ||||||||||||
Prepaid expenses and other current assets | 3,170 | 487 | ||||||||||||
Total Current Assets |
24,286 | 5,664 | ||||||||||||
Investments | 28,734 | 14,167 | ||||||||||||
Property, plant and equipment, net | 1,414 | 637 | ||||||||||||
Intangible assets, net | 182,153 | — | ||||||||||||
Goodwill | 667,936 | — | ||||||||||||
Other assets | 766 | 1,096 | ||||||||||||
Total Assets |
$ | 905,289 | $ | 21,564 | ||||||||||
Liabilities and Stockholders' Deficit | ||||||||||||||
Accounts payable | $ | 3,248 | $ | 93 | ||||||||||
Accrued employee benefits | 9,273 | 3,779 | ||||||||||||
Accrued expenses | 2,477 | 1,009 | ||||||||||||
Related party payables | — | 347 | ||||||||||||
Related party notes payable - current | 14,000 | 1,000 | ||||||||||||
Notes payable - current | 625 | 912 | ||||||||||||
Patent installment payable - current | 1,225 | 775 | ||||||||||||
Obligation to issue equity | 4,158 | — | ||||||||||||
Warrant liability | 34,023 | — | ||||||||||||
Other current liabilities | 318 | 253 | ||||||||||||
Total Current Liabilities |
69,347 | 8,168 | ||||||||||||
Notes payable, net of current portion | 13,654 | 999 | ||||||||||||
Convertible promissory note, net | — | 1,120 | ||||||||||||
Convertible promissory note due to related party, net | — | 3,381 | ||||||||||||
Embedded derivative liability | — | 1,994 | ||||||||||||
Earnout liability | 14,752 | — | ||||||||||||
Stock-based compensation liability | 1,160 | — | ||||||||||||
Patent installment payable, net of current | 12,375 | 13,075 | ||||||||||||
Deferred income taxes | 27,893 | — | ||||||||||||
Other liabilities | 355 | 683 | ||||||||||||
Total Liabilities |
139,536 | 29,420 | ||||||||||||
Commitments and Contingencies (Note 19) | ||||||||||||||
Mezzanine Capital | ||||||||||||||
Redeemable Class I Units, no par value, 1,000,000 units authorized, issued and outstanding as of December 31, 2023 |
— | 2,912 | ||||||||||||
Redeemable Class PCTA Units, no par value, 3,982,675 units authorized, issued and outstanding as of December 31, 2023 |
— | 7,718 | ||||||||||||
Stockholders' Equity / Unitholders' Deficit | ||||||||||||||
Class B Preferred Units, no par value, 4,639,557 units authorized, and 4,109,961 units issued and outstanding as of December 31, 2023 |
— | 38,122 | ||||||||||||
Class B-1 Preferred Units, no par value, 2,600,000 units authorized, and 342,608 units issued and outstanding as of December 31, 2023 |
— | 3,323 | ||||||||||||
Class A Units, no par value, 10,975,000 units authorized, and 10,875,000 units issued and outstanding as of December 31, 2023 |
— | 1,950 | ||||||||||||
Class C Units, no par value, 1,585,125 units authorized, and 1,570,125 units issued and outstanding as of December 31, 2023 |
— | 844 | ||||||||||||
Preferred Stock, $0.0001 par value, 25,000,000 shares authorized, and 1,102,000 shares issued and outstanding as of December 31, 2024 |
— | — | ||||||||||||
Common Stock, $0.0001 par value, 250,000,000 shares authorized, and 44,597,154 shares issued and outstanding as of December 31, 2024 |
4 | — | ||||||||||||
Additional paid-in capital | 502,865 | — | ||||||||||||
Accumulated other comprehensive gain (loss) | 909 | — | ||||||||||||
Accumulated deficit | (78,802) | (64,284) | ||||||||||||
Total Innventure, Inc., Stockholders’ Equity/ Innventure LLC Unitholders' Deficit | 424,976 | (20,045) | ||||||||||||
Non-controlling interest | 340,777 | 1,559 | ||||||||||||
Total Stockholders' Equity/ Unitholders' Deficit |
765,753 | (18,486) | ||||||||||||
Total Liabilities, Mezzanine Capital and Equity |
$ | 905,289 | $ | 21,564 |
Successor | Predecessor | |||||||||||||||||||
October 2, 2024 through December 31, 2024 | January 1, 2024 through October 1, 2024 | Year ended December 31, 2023 | ||||||||||||||||||
Revenue | $ | 456 | $ | 764 | $ | 1,117 | ||||||||||||||
Operating Expenses | ||||||||||||||||||||
Cost of sales | 3,752 | 777 | — | |||||||||||||||||
General and administrative | 29,652 | 26,608 | 17,589 | |||||||||||||||||
Sales and marketing | 2,009 | 4,178 | 3,205 | |||||||||||||||||
Research and development | 5,340 | 5,978 | 4,001 | |||||||||||||||||
Total Operating Expenses |
40,753 | 37,541 | 24,795 | |||||||||||||||||
Loss from Operations |
(40,297) | (36,777) | (23,678) | |||||||||||||||||
Non-operating (Expense) and Income | ||||||||||||||||||||
Interest expense, net | (1,132) | (1,300) | (1,224) | |||||||||||||||||
Net gain (loss) from investments | — | 11,547 | (6,448) | |||||||||||||||||
Net (loss) gain on investments - due to related parties | — | (468) | 232 | |||||||||||||||||
Change in fair value of financial liabilities | (20,946) | (478) | 766 | |||||||||||||||||
Equity method investment (loss) income | (902) | 893 | (632) | |||||||||||||||||
Loss on conversion of promissory notes | — | (1,119) | — | |||||||||||||||||
Write-off of loan commitment fee asset | (10,041) | — | — | |||||||||||||||||
Miscellaneous other expense | (57) | (64) | — | |||||||||||||||||
Total Non-operating (Expense) Income |
(33,078) | 9,011 | (7,306) | |||||||||||||||||
Loss before Income Taxes | (73,375) | (27,766) | (30,984) | |||||||||||||||||
Income tax expense (benefit) | (2,742) | 432 | — | |||||||||||||||||
Net Loss |
(70,633) | (28,198) | (30,984) | |||||||||||||||||
Less: net loss attributable to | ||||||||||||||||||||
Non-redeemable non-controlling interest | (8,339) | (11,762) | (139) | |||||||||||||||||
Net Loss Attributable to Innventure, Inc. Stockholders / Innventure LLC Unitholders |
(62,294) | (16,436) | (30,845) | |||||||||||||||||
Basic and diluted loss per share | $ | (1.42) | ||||||||||||||||||
Basic and diluted weighted average common shares | 43,951,279 | |||||||||||||||||||
Other comprehensive income, net of taxes: | ||||||||||||||||||||
Unrealized gain on available-for-sale debt securities - related party | 909 | 62 | — | |||||||||||||||||
Total other comprehensive loss, net of taxes | 909 | 62 | — | |||||||||||||||||
Total comprehensive loss, net of taxes | (69,724) | (28,136) | (30,984) | |||||||||||||||||
Less: comprehensive income attributable to | ||||||||||||||||||||
Non-redeemable non-controlling interest | (8,339) | (11,762) | (139) | |||||||||||||||||
Net Comprehensive Loss Attributable to Innventure, Inc. Stockholders / Innventure LLC Unitholders | $ | (61,385) | $ | (16,374) | $ | (30,845) | ||||||||||||||
Class I Amount | Class PCTA Amount | Total | |||||||||||||||
December 31, 2022 |
$ | 2,984 | $ | 12,882 | $ | 15,866 | |||||||||||
Proceeds from capital calls to unitholders | 130 | — | 130 | ||||||||||||||
Accretion of redeemable units to redemption value | (202) | (5,164) | (5,366) | ||||||||||||||
December 31, 2023 |
2,912 | 7,718 | 10,630 | ||||||||||||||
Accretion of redeemable units to redemption value | 1,565 | 10,385 | 11,950 | ||||||||||||||
October 1, 2024 | $ | 4,477 | $ | 18,103 | $ | 22,580 |
Class B Preferred | Class B-1 Preferred | Class A | Class C | Accumulated Deficit | Accumulated OCI | Non-Controlling Interest | Total Unitholders' Deficit | ||||||||||||||||||||||||||||||||||||||||
December 31, 2022 (Predecessor) | $ | 20,803 | $ | 3,323 | $ | 1,950 | $ | 639 | $ | (38,564) | $ | — | $ | 656 | $ | (11,193) | |||||||||||||||||||||||||||||||
Net loss | — | — | — | — | (30,845) | — | (139) | (30,984) | |||||||||||||||||||||||||||||||||||||||
Non-controlling interest acquired | — | — | — | — | — | — | 337 | 337 | |||||||||||||||||||||||||||||||||||||||
Issuance of units, net of issuance costs | 17,319 | — | — | — | — | — | — | 17,319 | |||||||||||||||||||||||||||||||||||||||
Unit-based compensation | — | — | — | 205 | — | — | 705 | 910 | |||||||||||||||||||||||||||||||||||||||
Distributions to unitholders | — | — | — | — | (241) | — | — | (241) | |||||||||||||||||||||||||||||||||||||||
Accretion of redeemable units to redemption value | — | — | — | — | 5,366 | — | — | 5,366 | |||||||||||||||||||||||||||||||||||||||
December 31, 2023 (Predecessor) | 38,122 | 3,323 | 1,950 | 844 | (64,284) | — | 1,559 | (18,486) | |||||||||||||||||||||||||||||||||||||||
Net loss | — | — | — | — | (16,436) | — | (11,762) | (28,198) | |||||||||||||||||||||||||||||||||||||||
Other comprehensive loss, net of taxes | — | — | — | — | — | 62 | — | 62 | |||||||||||||||||||||||||||||||||||||||
Units issued to non-controlling interest | — | — | — | — | — | — | 13,921 | 13,921 | |||||||||||||||||||||||||||||||||||||||
Issuance of units, net of issuance costs | 13,561 | — | — | — | — | — | — | 13,561 | |||||||||||||||||||||||||||||||||||||||
Unit-based compensation | — | — | — | 137 | — | — | 919 | 1,056 | |||||||||||||||||||||||||||||||||||||||
Issuance of units to non-controlling interest in exchange of convertible promissory notes | — | — | — | — | — | — | 8,443 | 8,443 | |||||||||||||||||||||||||||||||||||||||
Accretion of redeemable units to redemption value | — | — | — | — | (11,950) | — | — | (11,950) | |||||||||||||||||||||||||||||||||||||||
October 1, 2024 (Predecessor) | $ | 51,683 | $ | 3,323 | $ | 1,950 | $ | 981 | $ | (92,670) | $ | 62 | $ | 13,080 | $ | (21,591) |
Series B Preferred Stock | Common Stock | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Additional Paid-In Capital | Accumulated Deficit | Accumulated OCI | Non-Controlling Interest | Total Stockholders' Equity | |||||||||||||||||||||||||||||||||||||||||||||
October 2, 2024 (Successor) | — | $ | — | — | $ | — | $ | 11,342 | $ | (15,845) | $ | — | $ | — | $ | (4,503) | |||||||||||||||||||||||||||||||||||||
Effect of acquisition of Innventure LLC | — | — | 43,589,850 | 4 | 461,064 | — | — | 343,030 | 804,098 | ||||||||||||||||||||||||||||||||||||||||||||
Reclassification of warrants from liability to equity | — | — | — | — | 1,265 | — | — | — | 1,265 | ||||||||||||||||||||||||||||||||||||||||||||
Issuance of common shares, net of issuance costs | — | — | 160,000 | — | 2,083 | — | — | — | 2,083 | ||||||||||||||||||||||||||||||||||||||||||||
Issuance of preferred shares, net of issuance costs | 1,102,000 | — | — | — | 9,965 | — | — | — | 9,965 | ||||||||||||||||||||||||||||||||||||||||||||
Issuance of common shares from warrant exercises | — | — | 259,309 | — | 2,982 | — | — | — | 2,982 | ||||||||||||||||||||||||||||||||||||||||||||
Net loss | — | — | — | — | — | (62,294) | — | (8,339) | (70,633) | ||||||||||||||||||||||||||||||||||||||||||||
Other comprehensive gain, net of taxes | — | — | — | — | — | — | 909 | — | 909 | ||||||||||||||||||||||||||||||||||||||||||||
Non-controlling interest acquired | — | — | — | — | — | — | — | 4,129 | 4,129 | ||||||||||||||||||||||||||||||||||||||||||||
Distributions to Stockholders | — | — | — | — | — | (663) | — | — | (663) | ||||||||||||||||||||||||||||||||||||||||||||
Vesting of contingent at risk sponsor shares | — | — | 587,995 | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation | — | — | — | — | 14,381 | — | — | 1,957 | 16,338 | ||||||||||||||||||||||||||||||||||||||||||||
Accrued preferred dividends | — | — | — | — | (217) | — | — | — | (217) | ||||||||||||||||||||||||||||||||||||||||||||
December 31, 2024 (Successor) | 1,102,000 | $ | — | 44,597,154 | $ | 4 | $ | 502,865 | $ | (78,802) | $ | 909 | $ | 340,777 | $ | 765,753 |
Successor | Predecessor | |||||||||||||||||||
October 2, 2024 through December 31, 2024 | January 1, 2024 through October 1, 2024 | Year ended December 31, 2023 | ||||||||||||||||||
Cash Flows Used in Operating Activities | ||||||||||||||||||||
Net loss | $ | (70,633) | $ | (28,198) | $ | (30,984) | ||||||||||||||
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities: | ||||||||||||||||||||
Stock-based compensation |
16,338 | 1,056 | 910 | |||||||||||||||||
Interest income on debt securities - related party | (106) | (110) | — | |||||||||||||||||
Change in fair value of financial liabilities | 20,946 | 478 | (766) | |||||||||||||||||
Change in fair value of payables due to related parties | — | 468 | (232) | |||||||||||||||||
Write-off of loan commitment fee asset | 10,041 | — | — | |||||||||||||||||
Non-cash interest expense on notes payable | 248 | 351 | 487 | |||||||||||||||||
Net (gain) loss on investments | — | (11,547) | 6,448 | |||||||||||||||||
Equity method investment gain (loss) | 902 | (893) | 632 | |||||||||||||||||
Loss on conversion of promissory notes | — | 1,119 | — | |||||||||||||||||
Deferred income taxes | (2,760) | 432 | — | |||||||||||||||||
Depreciation and amortization | 5,455 | 146 | 8 | |||||||||||||||||
Payment of patent installment | — | (250) | — | |||||||||||||||||
Non-cash rent costs | 63 | 185 | 192 | |||||||||||||||||
Accrued unpaid interest on note payable | 69 | 930 | — | |||||||||||||||||
Changes in operating assets and liabilities: | ||||||||||||||||||||
Accounts receivable | (166) | (117) | — | |||||||||||||||||
Prepaid expenses and other current assets | (1,301) | (1,353) | (218) | |||||||||||||||||
Inventory | (2,354) | (2,824) | — | |||||||||||||||||
Accounts payable | (11,211) | 6,013 | 9 | |||||||||||||||||
Accrued employee benefits | 1,656 | 3,838 | 3,181 | |||||||||||||||||
Accrued expenses | (484) | 674 | 1,230 | |||||||||||||||||
Stock-based compensation liability | 1,160 | — | — | |||||||||||||||||
Other current liabilities | (77) | (146) | (155) | |||||||||||||||||
Obligation to issue equity | 3,000 | 10,920 | — | |||||||||||||||||
Other assets | — | (20) | (218) | |||||||||||||||||
Net Cash Used in Operating Activities |
(29,214) | (18,848) | (19,476) | |||||||||||||||||
Cash Flows Provided by (Used in) Investing Activities | ||||||||||||||||||||
Purchase of shares in equity method investee | — | — | (2,000) | |||||||||||||||||
Contributions to equity method investee | — | — | (130) | |||||||||||||||||
Investment in debt securities - equity method investee | — | (7,400) | (2,600) | |||||||||||||||||
Advances to equity method investee | (4,240) | (135) | — | |||||||||||||||||
Acquisition of property, plant and equipment | (266) | (736) | (645) | |||||||||||||||||
Acquisition of intangible assets | (30) | — | — | |||||||||||||||||
Acquisition of net assets, net of cash acquired, through business combination | 16 | — | — | |||||||||||||||||
Proceeds from sale of investments | — | 2,314 | 708 | |||||||||||||||||
Cash withdrawn from trust as a result of business combination | 11,342 | — | — | |||||||||||||||||
Net Cash Provided by (Used in) Investing Activities |
6,822 | (5,957) | (4,667) | |||||||||||||||||
Cash Flows Provided by Financing Activities | ||||||||||||||||||||
Proceeds from issuance of equity, net of issuance costs | 15,383 | 13,122 | 16,009 | |||||||||||||||||
Proceeds from the issuance of equity to non-controlling interest, net of issuance costs | 4,169 | 13,859 | 337 | |||||||||||||||||
Proceeds from the issuance of convertible promissory note | — | — | 2,000 | |||||||||||||||||
Proceeds from issuance of debt securities, net of issuance costs | 19,455 | — | — | |||||||||||||||||
Payment of debts | (250) | (540) | (65) | |||||||||||||||||
Receipt of Capital from Class I Unitholder | — | — | 130 | |||||||||||||||||
Distributions to Stockholders | (663) | — | (241) | |||||||||||||||||
Proceeds from the issuance of promissory notes to related parties | — | 12,000 | 1,004 | |||||||||||||||||
Repayment of promissory note | (4,628) | — | — | |||||||||||||||||
Cash Flows Provided by Financing Activities |
33,466 | 38,441 | 19,174 | |||||||||||||||||
Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash | 11,074 | 13,636 | (4,969) | |||||||||||||||||
Cash, Cash Equivalents and Restricted Cash Beginning of period | 45 | 2,575 | 7,544 | |||||||||||||||||
Cash, Cash Equivalents and Restricted Cash End of period |
$ | 11,119 | $ | 16,211 | $ | 2,575 | ||||||||||||||
Successor | Predecessor |
|||||||||||||||||||
October 2, 2024 through December 31, 2024 | January 1, 2024 through October 1, 2024 | Year ended December 31, 2023 | ||||||||||||||||||
Supplemental Cash Flow Information | ||||||||||||||||||||
Cash paid for interest | $ | 991 | $ | 1,070 | $ | 297 | ||||||||||||||
Supplemental Disclosure of Noncash Financing Information | ||||||||||||||||||||
Accretion of redeemable units to redemption value | — | 11,950 | 5,366 | |||||||||||||||||
Debt discount and embedded derivative upon issuance | — | — | 1,119 | |||||||||||||||||
Issuance of units to non-controlling interest in exchange of convertible promissory notes | — | 7,324 | — | |||||||||||||||||
Conversion of working capital loans to equity method investees into investments in debt securities - related party | — | 2,600 | — | |||||||||||||||||
Transfer of liability warrants to equity warrants in the Business Combination | 1,265 | — | — | |||||||||||||||||
Initial recognition of loan commitment fee | 16,190 | — | — | |||||||||||||||||
Transfer of loan commitment fee asset | 6,694 | — | — |
Successor | Predecessor | S/P Combined (Non-GAAP) | Predecessor | ||||||||||||||||||||
Period from October 2, 2024 through December 31, 2024 | Period from January 1, 2024 through October 1, 2024 | Year ended December 31, 2024 | Year ended December 31, 2023 | ||||||||||||||||||||
Net Loss | (70,633) | (28,198) | (98,831) | (30,984) | |||||||||||||||||||
Interest expense, net(1) |
11,173 | 1,300 | 12,473 | 1,224 | |||||||||||||||||||
Depreciation and amortization expense | 5,455 | 146 | 5,601 | 8 | |||||||||||||||||||
Provision for income taxes | 2,742 | (432) | 2,310 | — | |||||||||||||||||||
EBITDA | (51,263) | (27,184) | (78,447) | (29,752) | |||||||||||||||||||
Transaction and other related costs(2) |
2,309 | 9,414 | 11,723 | 3,452 | |||||||||||||||||||
Change in fair value of financial liabilities(3) |
20,946 | 478 | 21,424 | (766) | |||||||||||||||||||
Stock based compensation(4) |
16,338 | 1,056 | 17,394 | 910 | |||||||||||||||||||
Adjusted EBITDA | (11,670) | (16,236) | (27,906) | (26,156) |